市場調査レポート
商品コード
1468151
眼科用粘弾性デバイス市場:製品、用途、エンドユーザー、地域別、2024~2032年Ophthalmic Viscoelastic Devices Market by Product, Application, End User, and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
眼科用粘弾性デバイス市場:製品、用途、エンドユーザー、地域別、2024~2032年 |
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2~3営業日
|
世界の眼科用粘弾性デバイス市場規模は、2023年に27億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに37億米ドルに達し、2024~2032年の成長率(CAGR)は3.52%になると予測しています。眼科手術件数の増加、広範な研究開発(R&D)活動、医療産業の急成長などが市場を牽引する主要要因です。
眼科用粘弾性デバイス(OVD)は、眼科手術の際に使用される医療機器です。緑内障、角膜移植、網膜硝子体手術、白内障手術などの眼科手術や数多くの眼科手術で使用されています。これらの器具は機械的外傷から眼球構造を保護し、組織を分割し、空間を作り、癒着を解消し、湿潤剤として作用し、あるいは外科手術を容易にする器具として機能します。OVDは、眼内レンズ(IOL)挿入時に眼球内の空間を維持し、前房を安定させ、深くし、前眼部手術時に眼球構造を保護するために広く使用されています。これらの器具は、前房内の圧力を作り出し、眼内を区画し、より迅速で安全な手術と患者の回復を助けます。
世界中で眼科手術の件数が増加していることが、市場成長を促進する主要要因の一つです。OVDは、組織の維持、空間保持、変位、安定化、保護に広く使用されています。これに伴い、眼科医療施設へのアクセスが向上し、眼疾患に対する意識が高まっていることも成長を促す要因となっています。さらに、複雑な眼科手術症例の増加や、2本の注射器を必要としない二相性の利点により、粘度適応型眼科用粘弾性が広く利用されていることも、市場の成長を後押ししています。これに加えて、粘圧適応型OVDは、小児白内障手術、虹彩弛緩症患者、外傷、フックスジストロフィーなどの複雑な眼科手術においても、術後の合併症を避けるために好まれており、これが市場の成長を後押ししています。これとは別に、凝集性OVDと分散性OVDを1つのユニットに収めたコンビネーションパッケージの採用は、手術中に同時に使用され、費用対効果が高く、品質基準を保証し、眼科外科医の活動を容易にするため、市場成長に弾みをつけています。さらに、高齢者人口の増加、糖尿病や加齢に伴う眼疾患の有病率の増加が市場成長にプラスの影響を与えています。その他の要因としては、消費者の支出能力の上昇、広範な研究開発(R&D)活動、医療産業の大幅な拡大、新しい眼科機器を導入するよう生産者に強制することで増加する視力障害を抑制するための様々な政府イニシアチブの実施などがあり、市場に明るい展望をもたらしています。
The global ophthalmic viscoelastic devices (OVD) market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.52% during 2024-2032. The increasing number of ophthalmic surgeries, extensive research and development (R&D) activities, and escalating growth in the healthcare industry represent some of the key factors driving the market.
Ophthalmic viscoelastic devices (OVD) are medical equipment used during eye surgeries. They are employed in ophthalmic and numerous eye surgeries, such as glaucoma, corneal transplant, and vitreoretinal and cataract surgery. These devices protect ocular structures from mechanical trauma, divide tissue, create space, resolve adhesions, act as a wetting agent, or as an instrument to facilitate the surgical procedure. OVDs are widely used to maintain space in the eye during intraocular lens (IOL) implantation, stabilize and deepen the anterior chamber, and protect ocular structures during anterior segment surgery. These devices assist in creating pressure within the anterior chamber, compartmentalizing inside the attention, and providing a faster and safer surgery with better recovery for the patients.
The increasing number of ophthalmic surgeries across the globe is one of the key factors driving the market growth. OVDs are widely used to maintain, preserve space, displace, stabilize, and protect tissues. In line with this, improving access to ophthalmic care facilities and rising awareness about ocular disorders are acting as another growth-inducing factor. Moreover, the widespread utilization of viscoadaptive ophthalmic viscosurgical devices due to the increasing number of complex ocular surgical cases and its biphasic benefit of eliminating the need for two syringes is propelling the market growth. In addition to this, viscoadaptive OVD is also preferred in complex ocular surgeries, such as pediatric cataract surgery, patient with floppy iris syndrome, trauma, Fuchs dystrophy, and other cases to avoid post-surgical complications, which, in turn, is favoring the market growth. Apart from this, the introduction of a combination package of cohesive and dispersive OVD contained in a single unit, that is used simultaneously during procedures and is cost-effective, ensures quality standards and eases out ophthalmic surgeons' activities is providing an impetus to the market growth. Additionally, the rising geriatric population and the increasing prevalence of diabetes and age-related ocular disorders are positively influencing the market growth. Other factors, including the rising expenditure capacities of consumers, extensive research and development (R&D) activities, significant expansion in the healthcare industry, and the implementation of various government initiatives to control the rising vision impairment by compelling producers to introduce new ophthalmic equipment, are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each segment of the global ophthalmic viscoelastic devices (OVD) market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, application, and end user.
Cohesive Ophthalmic Viscoelastic
Dispersive Ophthalmic Viscoelastic
A detailed breakup and analysis of the ophthalmic viscoelastic devices (OVD) market based on the product has also been provided in the report. This includes cohesive and dispersive ophthalmic viscoelastic. According to the report, cohesive ophthalmic viscoelastic accounted for the largest market share.
Cataract Surgery
Glaucoma Surgery
Corneal Transplant
Vitreoretinal Surgery
The report has provided a detailed breakup and analysis of the ophthalmic viscoelastic devices (OVD) market based on the application. This includes cataract surgery, glaucoma surgery, corneal transplant, and vitreoretinal surgery. According to the report, cataract surgery represented the largest segment.
Hospitals
Ophthalmic Clinics
Others
A detailed breakup and analysis of the ophthalmic viscoelastic devices (OVD) market based on the end user has also been provided in the report. This includes hospitals, ophthalmic clinics, and others. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for ophthalmic viscoelastic devices (OVD). Some of the factors driving the North America ophthalmic viscoelastic devices (OVD) market included extensive research and development (R&D) activities, the rising geriatric population, and the increasing prevalence of diabetes and age-related ocular disorders.
The report has also provided a comprehensive analysis of the competitive landscape in the global ophthalmic viscoelastic devices (OVD) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Alcon Inc., Altacor Limited, Bausch Health Companies Inc., Bohus Biotech Ab, Carl Zeiss Meditec Ag, Cima Technology Inc, Eyekon Medical Inc., Johnson & Johnson, RUMEX International Co., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.